X-Ray Crystallography Structure

X-ray crystallography structure determination reveals atomic molecular architecture enabling drug design. Crystal diffraction patterns map atomic positions. Electron density maps identify chemical bonds. Resolution depth determines structural detail. Structure validation confirms biological relevance.

Regulatory submissions employ crystallographic data supporting mechanism. Structure-based drug design optimises binding. Molecular dynamics simulations predict conformational changes. Post-approval monitoring confirms mechanism maintenance. Emerging cryo-EM provides alternative approaches.